June 24, 2004
SEAIR reports on developments in China and Middle East Operations
Edmonton, Alberta – June 24, 2004, SEAIR Inc. (“SDS” on the TSX Venture Exchange) is pleased to update activities arising out of international initiatives in China and the Middle East announced on March 22 and April 1, 2004. These included the initiation of Asia operations and the appointment of Henry Lee, VP- China Operations, and the receipt of a letter of intent from His Highness Sheikh Al Hassan Bun Ali Al Nuaimi for the establishment of a mutually owned company in The United
Arab Emirates (U.A.E.).
On June 18, 2004, Mr. Lee submitted the first quarterly report on his work in China. In April, he attended the Hortiflorexpo China 2004 and discussed SEAIR and its applications in oxygen diffusion and sterilization. A number of companies were approached with respect to joint venture projects, manufacture of SEAIR products, and interest in distribution agreements. Included in the Company’s corporate contacts is Langfang Jiutian Agriculture Engineering Co, one of the major agricultural engineering firms in China. Mr. Lee has made a number of recommendations arising out of strong interest in SEAIR Inc and its technology, and the management will determine a strategy over the next few weeks.
On June 7th, 2004, officials for the U.A.E. met with a SEAIR representative in Calgary. The substance of the April letter of intent was reaffirmed and it was mutually decided to complete application tests in North America prior to expanding distribution agreements through marketing networks in the Middle East.
While directing the initiatives in China and the U.A.E. through its representative in each region, SEAIR management has been active with the immediate North and Central American demand. It is the intention of management to continue to cultivate strong ties and develop marketing programs with SEAIR affiliates in China and the U.A.E. SEAIR will continue to update shareholders with progress in these markets as they develop.
SEAIR is engaged in the development, manufacture and sales of its proprietary diffusion and sterilization technologies with applications in various industries throughout North America and globally. The Corporation is actively involved in the North American Greenhouse industry within which it has been successful in the implementation and sales of its greenhouse nutrient diffusion technologies. Further applications of oxygenation and sterilization in industries such as Aquaculture, Aquaponics and Horticulture as well as other environmentally benign sterilization applications, and waste water bio-remediation are currently being developed and tested.
Parties interested in obtaining further information or receiving news releases and corporate documents from SEAIR may e-mail such request to ir@boardmarker.net or visit the SEAIR web site at:www.seair.ca
FOR FURTHER INFORMATION PLEASE CONTACT:
Boardmarker Consultancy Group
T: 403 517 2270
F: 403 517 2289
E: ir@boardmarker.net
Harold Kinasewich
SEAIR Inc.
T: 780 477 7188
F: 780 477 6622
E: seair@telus.net
This News Release includes certain “forward-looking statement” as such term is commonly understood. There can be no assurance that such statement will prove to be accurate. Actual results and future events could differ materially from those anticipated in such statements. Readers are cautioned not to place undue reliance on these forward-looking statements that speak only as of the date of this announcement. Important factors that could cause actual results to differ materially from the Corporation’s expectations include, among others, the ongoing results of current search. All subsequent written and oral forward-looking statements
attributable to the Corporation or persons acting on its behalf are expressly qualified in their entirety by this notice. While the Corporation anticipates that subsequent events and developments may cause the Corporation’s views to change, the Corporation specifically disclaims any obligation to update these forward-looking statements. These forward-looking statements should not be relied upon as representing the Corporation’s views as of any date subsequent to the date of this release.
THE TSX VENTURE EXCHANGE HAS NOT REVIEWED AND DOES NOT ACCEPT RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.
